Published

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: NeuroImage. Clinical
Date: 2016-01-01
Source: PubMed
DOI: 10.1016/j.nicl.2015.08.009
PubMed: 26909323

Authors

Kraehenmann R Schmidt A Friston K Preller KH Seifritz E Vollenweider FX

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Brain Imaging Receptor Pharmacology Emotional Processing Other

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions2026-07-02 Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration2026-04-10 Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19 Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review2026-03-09 The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.2016-01-01

Related papers

Psilocybin therapy: A novel approach to treating depressionInternational Journal of Surgery Global Health · 2023-06-02